Table 1.
Demographics of generalized generalized epilepsy (GGE) patients, subdivided by clinical feature, and healthy controls.
| # Runs | # Males | # Females | Age (years±SD) | Duration (years±SD) | # Current Drugs | # Failed Drugs | |
|---|---|---|---|---|---|---|---|
| GGE (All) | 152 | 32 | 40 | 31.3±11.5 | 14.5±11.4 | 1.50 | 2.05 |
| GGE (Seizures−) | 107 | 19 | 30 | 32.3±10.9 | 14.9±10.7 | 1.29 | 1.47 |
| GGE (Seizures+) | 45 | 13 | 10 | 29.1±12.6 | 13.6±13.1 | 1.96 | 3.30 |
| GGE (GSWD−) | 108 | 18 | 31 | 31.9±11.3 | 14.9±10.5 | 1.33 | 1.76 |
| GGE (GSWD+) | 44 | 14 | 9 | 29.9±12.1 | 13.6±13.4 | 1.87 | 2.70 |
| GGE (JME) | 73 | 18 | 18 | 27.8±8.8 | 13.2±9.0 | 1.44 | 2.25 |
| GGE (Other) | 79 | 14 | 22 | 34.8±12.9 | 15.8±13.4 | 1.56 | 1.86 |
| Control | 67 | 22 | 16 | 30.9±10.2 |
Mean age and duration of epilepsy at scanning (± standard deviation) are given in years. Seizures− = epilepsy patients who were seizure-free during the three months leading up to scanning. Seizures+ = GGE patients who experienced at least one seizure during the three months leading up to scanning. JME = juvenile myoclonic epilepsy.